ContextVision AB (OSL:CONTX) ROC (Joel Greenblatt) %: 17.48% (As of Mar. 2026) — 90% Below Median


OSL:CONTX ContextVision AB OSL:CONTX
78 GF Score
Price kr3.33
GF Value kr5.12
Valuation Significantly Undervalued
! 2 Warning Signs
View Full Analysis

What is ContextVision AB ROC (Joel Greenblatt) %?

ContextVision AB OSL:CONTX -3.20% 78 ROC (Joel Greenblatt) % is 17.48% as of Mar. 2026, which is 90% below its 10-year median of 183.44. GuruFocus rates OSL:CONTX with a GF Score™ of 78/100 and a GF Value™ of kr5.12 (Significantly Undervalued). The stock has 2 warning signs investors should review. Among 668 Healthcare Providers & Services companies, ContextVision AB ranks better than 65.27% on this metric.

Joel Greenblatt defined Return on Capital differently in his book The Little Book That Still Beats the Market (Little Books. Big Profits). He defines ROC (Joel Greenblatt) % as EBIT divided by the total of Property, Plant and Equipment and net working capital. ContextVision AB's annualized ROC (Joel Greenblatt) % for the quarter that ended in Mar. 2026 was 17.48%.

The historical rank and industry rank for ContextVision AB's ROC (Joel Greenblatt) % or its related term are showing as below:

OSL:CONTX' s ROC (Joel Greenblatt) % Range Over the Past 10 Years
Min: -46.48   Med: 183.44   Max: 346.44
Current: 21.39

During the past 13 years, ContextVision AB's highest ROC (Joel Greenblatt) % was 346.44%. The lowest was -46.48%. And the median was 183.44%.

OSL:CONTX's ROC (Joel Greenblatt) % is ranked better than
65.27% of 668 companies
in the Healthcare Providers & Services industry
Industry Median: 12.47 vs OSL:CONTX: 21.39

ContextVision AB's 5-Year average Growth Rate of ROC (Joel Greenblatt) % was -56.70% per year.


ContextVision AB  (OSL:CONTX) ROC (Joel Greenblatt) % Explanation

The way Joel Greenblatt defines Return on Capital is a more accurate measure of how efficiently the company generates returns onthe capital actually invested in the business. EBIT is used instead of net income because the tax and interest payment may be affected by factors other than the core business operation. Intangible assets are not included in the calculation because they don't need to be replaced.

Joel Greenblatt uses his definition of Return on Capital and Earnings Yield (Joel Greenblatt) % to rank companies.


ContextVision AB ROC (Joel Greenblatt) % Related Terms


ContextVision AB ROC (Joel Greenblatt) % Historical Data

* Premium members only.

The historical data trend for ContextVision AB's ROC (Joel Greenblatt) % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

ContextVision AB ROC (Joel Greenblatt) % Chart

ContextVision AB Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
ROC (Joel Greenblatt) %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 343.08 263.41 308.40 220.96 1.25

ContextVision AB Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
ROC (Joel Greenblatt) % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -57.51 8.08 -5.34 63.22 17.48

OSL:CONTX vs VEEV, BTSG, TEM: ROC (Joel Greenblatt) % Comparison

For the Health Information Services subindustry, ContextVision AB's ROC (Joel Greenblatt) %, along with its competitors' market caps and ROC (Joel Greenblatt) % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


ContextVision AB ROC (Joel Greenblatt) % vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, ContextVision AB's ROC (Joel Greenblatt) % distribution charts can be found below:

* The bar in red indicates where ContextVision AB's ROC (Joel Greenblatt) % falls into.


OSL:CONTX
78GF Score
ContextVision AB OSL:CONTX
ROC (Joel Greenblatt) % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

ContextVision AB ROC (Joel Greenblatt) % Calculation

Joel Greenblatt defined Return on Capital differently in his book The Little Book That Still Beats the Market (Little Books. Big Profits) . He defines Return on Capital as follows:

ROC (Joel Greenblatt) %=EBIT/Average of (Net fixed Assets + Net Working Capital)

EBIT stands for Earnings Before Interest and Taxes.

Fixed Assets are also known as non-current assets. They include the Property, Plant and Equipment that the firm needs in its operation.

GuruFocus calculates net working capital as: (Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Deferred Revenue + Other Current Liabilities). We're trying to account for OPERATING assets and liabilities (part of daily business) when calculating working capital. Cash and marketable securities are considered NON-OPERATING assets and are not included in calculation. We will also back out all interest bearing debt, short term debt and the portion of long term debt that is due in the current period from the current liabilities. This debt will be considered when computing cost of capital and it would be inappropriate to count it twice.

Working Capital(Q: Dec. 2025 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(21.58 + 1.152 + 6.175) - (3.681 + 0 + 18.184)
=7.042

Working Capital(Q: Mar. 2026 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(32.546 + 1.444 + 0) - (0 + 0 + 24.23)
=9.76

When net working capital is negative, 0 is used.

So ROC (Joel Greenblatt) % of ContextVision AB for the quarter that ended in Mar. 2026 can be restated as:

ROC (Joel Greenblatt) %(Q: Mar. 2026 )
=EBIT/Average of (Net fixed Assets + Net Working Capital)
=EBIT/Average of (Property, Plant and Equipment+Net Working Capital)
     Q: Dec. 2025  Q: Mar. 2026
=EBIT/( ( (Property, Plant and Equipment + Net Working Capital) + (Property, Plant and Equipment + Net Working Capital) )/ count )
=5.304/( ( (22.139 + max(7.042, 0)) + (21.733 + max(9.76, 0)) )/ 2 )
=5.304/( ( 29.181 + 31.493 )/ 2 )
=5.304/30.337
=17.48 %

Note: The EBIT data used here is four times the quarterly (Mar. 2026) EBIT data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a ROC (Joel Greenblatt) % of 17.48% mean?
ContextVision AB (OSL:CONTX) has a ROC (Joel Greenblatt) % of 17.48% as of Mar. 2026. Joel Greenblatt's return on capital is the ratio of EBIT to average fixed assets and net working capital. View historical data on ContextVision AB and its competitors. This is 90% below median its historical median of 183.44. According to the industry distribution chart, ContextVision AB ranks #232 out of 668 companies in the Healthcare Providers & Services industry, placing it in the top 34.7%.
Is ContextVision AB's ROC (Joel Greenblatt) % too high?
ContextVision AB's current ROC (Joel Greenblatt) % of 17.48% is 90% below median its 10-year median of 183.44. The Healthcare Providers & Services industry median ROC (Joel Greenblatt) % is 12.47. ContextVision AB's value of 17.48% is 40.2% above this industry median. Based on the distribution chart, ContextVision AB ranks #232 out of 668 companies in the Healthcare Providers & Services industry, which is above the industry midpoint. Overall, ContextVision AB has a GF Score™ of 78/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does ContextVision AB's ROC (Joel Greenblatt) % compare to VEEV and BTSG?
According to the Healthcare Providers & Services industry distribution chart, ContextVision AB ranks #232 out of 668 companies for ROC (Joel Greenblatt) %. This puts ContextVision AB in the upper half of its industry. The industry median ROC (Joel Greenblatt) % is 12.47. ContextVision AB's value of 17.48% is 40.2% above this benchmark. While the company's 10-year median is 183.44 vs. the industry median of 12.47, ContextVision AB has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROC (Joel Greenblatt) % for a Healthcare Providers & Services company?
The median ROC (Joel Greenblatt) % among Healthcare Providers & Services companies is 12.47, based on 668 companies in the industry. Companies in the top quartile (top 25%) have a ROC (Joel Greenblatt) % significantly above this median, while those in the bottom quartile fall well below. However, ROC (Joel Greenblatt) % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. ContextVision AB's current ROC (Joel Greenblatt) % of 17.48% is 40.2% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROC (Joel Greenblatt) % mean?
A high ROC (Joel Greenblatt) % can signal that a stock is expensive relative to its fundamentals. Joel Greenblatt's return on capital is the ratio of EBIT to average fixed assets and net working capital. View historical data on ContextVision AB and its competitors. For the Healthcare Providers & Services industry, the median ROC (Joel Greenblatt) % is 12.47 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. ContextVision AB's current ROC (Joel Greenblatt) % is 17.48%, which is 90% below median its own 10-year median of 183.44. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is ContextVision AB stock overvalued right now?
Based on GuruFocus' analysis, ContextVision AB (OSL:CONTX) is currently considered Significantly Undervalued. The stock's GF Value™ is kr5.12, compared to a current price of kr3.33 — trading 35% below its estimated fair value. The current ROC (Joel Greenblatt) % is 17.48%, which is 90% below median its 10-year median of 183.44 and 40.2% above the Healthcare Providers & Services industry median of 12.47. ContextVision AB's overall GF Score™ is 78/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROC (Joel Greenblatt) % calculated?
ROC (Joel Greenblatt) % is calculated from a company's financial statements. For ContextVision AB (OSL:CONTX), the current ROC (Joel Greenblatt) % is 17.48% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is ContextVision AB (OSL:CONTX) Overvalued in 2026?

Based on GuruFocus' analysis, ContextVision AB stock appears to be undervalued. The current stock price of kr3.33 is trading 35% below its estimated GF Value™ of kr5.12. GuruFocus considers ContextVision AB to be Significantly Undervalued.

Key valuation signals for OSL:CONTX:

  • ROC (Joel Greenblatt) %: 17.48% (90% below median its 10-year median of 183.44)
  • GF Value™: kr5.12 vs. price of kr3.33 (35% below fair value)
  • GF Score™: 78/100 with 2 warning signs
  • Industry Position: 40.2% above the Healthcare Providers & Services median (#232 of 668)

No single metric tells the full story. See the OSL:CONTX stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


ContextVision AB Business Description

Other Exchanges COVo:Sweden
Address Gamla Brogatan 26, Stockholm, SWE, SE-111 20
ContextVision AB is a medical technology company. It develops and sells image enhancement software for medical diagnosis and artificial intelligence. Its product portfolio includes image enhancement software for 2D/3D/4D (dimensional) ultrasound, magnetic resonance imaging (MRI), X-Ray, radiography, and mammography. Its geographical segments are Asia, Europe, and America.
78GF Score

Get the complete analysis for OSL:CONTX

ROC (Joel Greenblatt) % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

kr3.33
Price
kr5.12
GF Value